Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Hematology/Oncology Clinics of North America
|
August 31, 2019
Advances in T-cell Immunotherapies
David F Stroncek, Opal Reddy, Steven Highfill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 24, 2013
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity
Wangko Lundström, Steven Highfill, Scott T R Walsh, et al.
Journal of Translational Medicine
|
March 17, 2017
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
David F Stroncek, Daniel W Lee, Jiaqiang Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 9, 2004
Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses
Tomar Ghansah, Kim H T Paraiso, Steven Highfill, et al.
Cytotherapy
|
April 16, 2018
Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells
Ping Jin, Wenjing Chen, Jiaqiang Ren, et al.
Clinical Hematology International
|
October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument
Sandhya R Panch, Opal L Reddy, Katherine Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 15, 2025
Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia
Alexandra Dreyzin, Lipei Shao, Yihua Cai, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2024
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus
Stefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation
Elizabeth M Holland, John C Molina, Kniya Dede, et al.
Nature Medicine
|
February 9, 2021
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nisha B Nagarsheth, Scott M Norberg, Andrew L Sinkoe, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Hematology/Oncology Clinics of North America
|
August 31, 2019
Advances in T-cell Immunotherapies
David F Stroncek, Opal Reddy, Steven Highfill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 24, 2013
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity
Wangko Lundström, Steven Highfill, Scott T R Walsh, et al.
Journal of Translational Medicine
|
March 17, 2017
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
David F Stroncek, Daniel W Lee, Jiaqiang Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 9, 2004
Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses
Tomar Ghansah, Kim H T Paraiso, Steven Highfill, et al.
Cytotherapy
|
April 16, 2018
Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells
Ping Jin, Wenjing Chen, Jiaqiang Ren, et al.
Clinical Hematology International
|
October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument
Sandhya R Panch, Opal L Reddy, Katherine Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 15, 2025
Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia
Alexandra Dreyzin, Lipei Shao, Yihua Cai, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2024
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus
Stefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation
Elizabeth M Holland, John C Molina, Kniya Dede, et al.
Nature Medicine
|
February 9, 2021
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nisha B Nagarsheth, Scott M Norberg, Andrew L Sinkoe, et al.
Page
of 2